Peptide modified polymeric micelles specific for breast cancer cells

Bioconjugate Chemistry

Volumn 24, Issue 4, 2013, Pages 560-570

  Mathews, Anu Stella ^a   Ahmed, Sahar ^a   Shahin, Mostafa ^a   Lavasanifar, Afsaneh ^a   Kaur, Kamaljit ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLENDING; CELL CULTURE; CELLS; DISEASES; ETHYLENE; LIGHT SCATTERING; MICELLES; POLYETHYLENE OXIDES;

AS-LIGANDS; BREAST CANCER; BREAST CANCER CELLS; CANCER CELL TARGETING; CANCER-TARGETING; CARRIER SYSTEMS; DIBLOCKS; POLY(-CAPROLACTONE); POLYMERIC MICELLE; TARGETING PEPTIDES;

PEPTIDES;

ARGINYLGLYCINYLASPRAGYLPROLYNYLALANYLGLUTAMINYLGLYCINYLARGINYLLEUCINE; MACROGOL; PEPTIDE; POLYCAPROLACTONE; TRYPTHOPHENYLGLUTAMYLALANYLALANYLGLUTAMYLARGINYLLEUCINE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG STRUCTURE; DRUG TARGETING; DYNAMIC LIGHT SCATTERING; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; HYDROPHOBICITY; LIGHT SCATTERING; LIPOPHILICITY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICELLE; MOLECULAR PROBE; PROTON NUCLEAR MAGNETIC RESONANCE; ZETA POTENTIAL;

EID: 84876478348     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc3004364     Document Type: Article

References (52)

1. Chidambaram, M., Manavalan, R., and Kathiresan, K. (2011) Nanotherapeutics to overcome conventional cancer chemotherapy limitations J. Pharm. Pharm. Sci. 14, 67-77
2. Chang, DK, C. C., Kuo, S. Y., Lin, W. C., Lo, A., Wang, Y. P., Li, P. C., and Wu, H. C. (2009) Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors J. Biol. Chem. 284, 12905-12916
3. Laakkonen, P., Zhang, L., and Ruoslahti, E. (2008) Peptide targeting of tumor lymph vessels Ann. N.Y. Acad. Sci. 1131, 37-43
4. Shapira, A., Livney, Y. D., Broxterman, H. J., and Assaraf, Y. G. (2011) Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance Drug Resist. Updates 14, 150-63
5. Ruoslahti, E., Duza, T., and Zhang, L. (2005) Vascular homing peptides with cell-penetrating properties Curr. Pharm. Des. 11, 3655-60
6. Del Vecchio, CA, L. G. and Wong, A. J. (2012) Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas Expert Rev. Vaccines 11, 133-144
7. Hwang, M., Moretti, L., and Lu, B. (2009) HSP90 inhibitors: multi-targeted antitumor effects and novel combinatorial therapeutic approaches in cancer therapy Curr. Med. Chem. 16, 3081-92
8. Guillemard, V. and Saragovi, H. U. (2004) Novel approaches for targeted cancer therapy Curr. Cancer Drug Targets 4, 313-26
9. Diermeier-Daucher, S., Breindl, S., Buchholz, S., Ortmann, O., and Brockhoff, G. (2011) Modular anti-EGFR and anti-Her2 targeting of SK-BR-3 and BT474 breast cancer cell lines in the presence of ErbB receptor-specific growth factors Cytometry, Part A 79, 684-93
10. Chames, P. and Baty, D. (2000) Antibody engineering and its applications in tumor targeting and intracellular immunization FEMS Lett. 189, 1-8
11. Lewis Phillips, G. D., Li, G., Dugger, D. L., Crocker, L. M., Parsons, K. L., Mai, E., Blattler, W. A., Lambert, J. M., Chari, R. V., Lutz, R. J., Wong, W. L., Jacobson, F. S., Koeppen, H., Schwall, R. H., Kenkare-Mitra, S. R., Spencer, S. D., and Sliwkowski, M. X. (2008) Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate Cancer Res. 68, 9280-90
12. Aina, O. H., Sroka, T. C., Chen, M. L., and Lam, K. S. (2002) Therapeutic cancer targeting peptides Biopolymers 66, 184-99
13. Patra, C. R., Rupasinghe, C. N., Dutta, S. K., Bhattacharya, S., Wang, E., Spaller, M. R., and Mukhopadhyay, D. (2012) Chemically modified peptides targeting the PDZ domain of GIPC as a therapeutic approach for cancer ACS Chem. Biol. 7, 770-779
14. Skwarczynski, M., Hayashi, Y., and Kiso, Y. (2006) Paclitaxel prodrugs: toward smarter delivery of anticancer agents J. Med. Chem. 49, 7253-69
15. Junutula, J. R., Raab, H., Clark, S., Bhakta, S., Leipold, D. D., Weir, S., Chen, Y., Simpson, M., Tsai, S. P., Dennis, M. S., Lu, Y., Meng, Y. G., Ng, C., Yang, J., Lee, C. C., Duenas, E., Gorrell, J., Katta, V., Kim, A., McDorman, K., Flagella, K., Venook, R., Ross, S., Spencer, S. D., Lee Wong, W., Lowman, H. B., Vandlen, R., Sliwkowski, M. X., Scheller, R. H., Polakis, P., and Mallet, W. (2008) Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index Nat. Biotechnol. 26, 925-32
16. Josan, J. S., Handl, H. L., Sankaranarayanan, R., Xu, L., Lynch, R. M., Vagner, J., Mash, E. A., Hruby, V. J., and Gillies, R. J. (2011) Cell-specific targeting by heterobivalent ligands Bioconjugate Chem. 22, 1270-8
17. Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Greenwald, D. R., and Ruoslahti, E. (2010) Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs Science 328, 1031-5
18. Lee, YJ, L. S. (2012) Regression of hepatocarcinoma cells using RNA aptamer specific to alpha-fetoprotein Biochem. Biophys. Res. Commun. 417, 521-527
19. Kurosaki, T, H. N., Kawakami, S., Higuchi, Y., Nakamura, T., Kitahara, T., Hashida, M., and Sasaki, H. (2012) Self-assemble gene delivery system for molecular targeting using nucleic acid aptamer Gene 491, 205-209
20. Aina, O. H., Liu, R., Sutcliffe, J. L., Marik, J., Pan, C. X., and Lam, K. S. (2007) From combinatorial chemistry to cancer-targeting peptides Mol. Pharmaceutics 4, 631-51
21. Bugaj, J. E., Achilefu, S., Dorshow, R. B., and Rajagopalan, R. (2001) Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform J. Biomed. Opt. 6, 122-33
22. Zhang, L., Yin, G., Yan, D., Wei, Y., Ma, C., Huang, Z., Liao, X., Yao, Y., Chen, X., and Hao, B. (2011) In vitro screening of ovarian tumor specific peptides from a phage display peptide library Biotechnol. Lett. 33, 1729-35
23. Brown, K. C. (2010) Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications Curr. Pharm. Des. 16, 1040-54
24. Chang, D. K., Lin, C. T., Wu, C. H., and Wu, H. C. (2009) A novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancer PLoS ONE 4, e4171
25. Zarovni, N., Monaco, L., and Corti, A. (2004) Inhibition of tumor growth by intramuscular injection of cDNA encoding tumor necrosis factor alpha coupled to NGR and RGD tumor-homing peptides Hum. Gene Ther. 15, 373-82
26. Arap, W., Pasqualini, R., and Ruoslahti, E. (1998) Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model Science 279, 377-80
27. Mukhopadhyay, S., Barnes, C. M., Haskel, A., Short, S. M., Barnes, K. R., and Lippard, S. J. (2008) Conjugated platinum(IV)-peptide complexes for targeting angiogenic tumor vasculature Bioconjugate Chem. 19, 39-49
28. Curnis, F., Arrigoni, G., Sacchi, A., Fischetti, L., Arap, W., Pasqualini, R., and Corti, A. (2002) Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells Cancer Res. 62, 867-74
29. Corti, A, C. F., Arap, W., and Pasqualini, R. (2008) The neovasculature homing motif NGR: more than meets the eye Blood 112, 2628-2635
30. Simnick, A. J., Amiram, M., Liu, W., Hanna, G., Dewhirst, M. W., Kontos, C. D., and Chilkoti, A. (2011) In vivo tumor targeting by a NGR-decorated micelle of a recombinant diblock copolypeptide J. Controlled Release: official journal of the Controlled Release Society 155, 144-51
31. Askoxylakis, V., Mier, W., Zitzmann, S., Ehemann, V., Zhang, J., Kramer, S., Beck, C., Schwab, M., Eisenhut, M., and Haberkorn, U. (2006) Characterization and development of a peptide (p160) with affinity for neuroblastoma cells J. Nucl. Med. 47, 981-8
32. Askoxylakis, V., Zitzmann, S., Mier, W., Graham, K., Kramer, S., von Wegner, F., Fink, R. H., Schwab, M., Eisenhut, M., and Haberkorn, U. (2005) Preclinical evaluation of the breast cancer cell-binding peptide, p160 Clin. Cancer Res. 11, 6705-12
33. Zhang, J, S. H. and Schwab, M. (2001) Neuroblastoma tumor cell-binding peptides identified through random peptide phage display Cancer Lett. 171, 153-164
34. Ahmed, S., Mathews, A. S., Byeon, N., Lavasanifar, A., and Kaur, K. (2010) Peptide arrays for screening cancer specific peptides Anal. Chem. 82, 7533-41
35. Wakebayashi, D, N. N., Yamasaki, Y., Itaka, K., Kanayama, N., Harada, A., Nagasaki, Y., and Kataoka, K. (2004) Lactose-conjugated polyion complex micelles incorporating plasmid DNA as a targetable gene vector system: their preparation and gene transfecting efficiency against cultured HepG2 cells J. Controlled Release 95, 653-664
36. Christie, R. J., Matsumoto, Y., Miyata, K., Nomoto, T., Fukushima, S., Osada, K., Halnaut, J., Pittella, F., Kim, H. J., Nishiyama, N., and Kataoka, K. (2012) Targeted polymeric micelles for siRNA treatment of experimental cancer by intravenous injection ACS Nano 6, 5174-89
37. Nakanishi, T, F. S., Okamoto, K., Suzuki, M., Matsumura, Y., Yokoyama, M., Okano, T., Sakurai, Y., and Kataoka, K. (2001) Development of the polymer micelle carrier system for doxorubicin J. Controlled Release 74, 295-302
38. Xiong, XB, M. A., Uludaǧ, H., and Lavasanifar, A. (2007) Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells Biomacromolecules 8, 874-884
39. Gong, J, C. M., Zheng, Y., Wang, S., and Wang, Y. (2012) Polymeric micelles drug delivery system in oncology J. Controlled Release 159, 312-23
40. Shahin, M., Ahmed, S., Kaur, K., and Lavasanifar, A. (2011) Decoration of polymeric micelles with cancer-specific peptide ligands for active targeting of paclitaxel Biomaterials 32, 5123-33
41. Zhang, Y, W. X., Wang, J., Zhang, X., and Zhang, Q. (2011) Octreotide-modified polymeric micelles as potential carriers for targeted docetaxel delivery to somatostatin receptor overexpressing tumor cells Pharm. Res. 28, 1167-1178
42. McCusker, C. F., Kocienski, P. J., Boyle, F. T., Schätzlein, A. G., and Schätzleinc. (2002) Solid-phase synthesis of c(RGDfK) derivatives: on-resin cyclisation and lysine functionalisation Bioorg. Med. Chem. Lett. 12, 547-549
43. Wang, Y., Wang, X., Zhang, Y., Yang, S., Wang, J., Zhang, X., and Zhang, Q. (2009) RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells J. Drug Targeting 17, 459-67
44. Jule, E., Nagasaki, Y., and Kataoka, K. (2003) Lactose-installed poly(ethylene glycol)-poly(d,l-lactide) block copolymer micelles exhibit fast-rate binding and high affinity toward a protein bed simulating a cell surface. A surface plasmon resonance study Bioconjugate Chem. 14, 177-86
45. Yamamoto, Y., Nagasaki, Y., Kato, M., and Kataoka, K. (1999) Surface charge modulation of poly (ethylene glycol)-poly (d, l-lactide) block copolymer micelles: conjugation of charged peptides Colloids Surf., B 16, 135-146
46. Chambers, A. F. (2009) MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? Cancer Res. 69, 5292-3
47. Montel, V., Suzuki, M., Galloy, C., Mose, E. S., and Tarin, D. (2009) Expression of melanocyte-related genes in human breast cancer and its implications Differentiation 78, 283-91
48. Kalra, J., Anantha, M., Warburton, C., Waterhouse, D., Yan, H., Yang, Y. J., Strut, D., Osooly, M., Masin, D., and Bally, M. B. (2011) Validating the use of a luciferase labeled breast cancer cell line, MDA435LCC6, as a means to monitor tumor progression and to assess the therapeutic activity of an established anticancer drug, docetaxel (Dt) alone or in combination with the ILK inhibitor, QLT0267 Cancer Biol. Ther. 11, 826-38
49. Deutch-Kolevzon, R., Aserin, A., and Garti, N. (2011) Synergistic cosolubilization of omega-3 fatty acid esters and CoQ10 in dilutable microemulsions Chem. Phys. Lipids 164, 654-63
50. Soudy, R., Gill, A., Sprules, T., Lavasanifar, A., and Kaur, K. (2011) Proteolytically stable cancer targeting peptides with high affinity for breast cancer cells J. Med. Chem. 54, 7523-34
51. Shahin, M., Soudy, R., El-Sikhry, H., Seubert, J. M., Kaur, K., and Lavasanifar, A. (2012) Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin Cancer Lett. 10.1016/j.canlet.2012. 10.007
52. Shahin, M., Soudy, R., Aliabadi, H. M., Kneteman, N., Kaur, K., and Lavasanifar, A. (2013) Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity Biomaterials 34, 4089-97